DaVita Inc. (NYSE:DVA) Given Consensus Rating of “Hold” by Brokerages

Shares of DaVita Inc. (NYSE:DVA) have been assigned an average recommendation of “Hold” from the eight ratings firms that are presently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, four have issued a hold recommendation, two have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month target price among brokerages that have covered the stock in the last year is $199.1667.

Several brokerages recently issued reports on DVA. Zacks Research upgraded DaVita from a “hold” rating to a “strong-buy” rating in a research report on Thursday, May 7th. Barclays lifted their target price on DaVita from $158.00 to $194.00 and gave the company an “equal weight” rating in a research note on Thursday, May 7th. Deutsche Bank Aktiengesellschaft raised DaVita from a “hold” rating to a “buy” rating and boosted their target price for the company from $126.00 to $220.00 in a report on Wednesday, May 6th. Truist Financial increased their price target on DaVita from $158.00 to $205.00 and gave the stock a “hold” rating in a report on Friday, May 8th. Finally, Wall Street Zen upgraded shares of DaVita from a “hold” rating to a “buy” rating in a research report on Saturday, February 21st.

DaVita Stock Performance

Shares of DaVita stock opened at $199.43 on Friday. The company has a market capitalization of $12.80 billion, a P/E ratio of 18.50, a PEG ratio of 0.63 and a beta of 0.84. DaVita has a 1 year low of $101.00 and a 1 year high of $202.69. The company’s fifty day moving average is $158.38 and its two-hundred day moving average is $135.58.

DaVita (NYSE:DVA) last announced its earnings results on Tuesday, May 5th. The company reported $2.87 EPS for the quarter, beating analysts’ consensus estimates of $2.33 by $0.54. DaVita had a net margin of 5.65% and a negative return on equity of 270.37%. The business had revenue of $3.42 billion during the quarter, compared to analysts’ expectations of $3.36 billion. During the same period in the prior year, the company earned $2.00 earnings per share. The business’s revenue was up 6.0% compared to the same quarter last year. DaVita has set its FY 2026 guidance at 14.100-15.200 EPS. As a group, equities analysts expect that DaVita will post 15.07 earnings per share for the current year.

Insider Activity at DaVita

In other news, CFO Joel Ackerman sold 51,471 shares of DaVita stock in a transaction dated Thursday, May 7th. The shares were sold at an average price of $192.10, for a total value of $9,887,579.10. Following the sale, the chief financial officer owned 132,434 shares of the company’s stock, valued at $25,440,571.40. The trade was a 27.99% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 1.50% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in DVA. Todd Asset Management LLC purchased a new stake in shares of DaVita in the third quarter valued at approximately $21,842,000. National Pension Service purchased a new position in DaVita in the third quarter worth $1,305,000. Doma Perpetual Capital Management LLC lifted its holdings in DaVita by 23.3% in the third quarter. Doma Perpetual Capital Management LLC now owns 355,574 shares of the company’s stock valued at $47,245,000 after acquiring an additional 67,214 shares during the period. Intech Investment Management LLC boosted its position in shares of DaVita by 122.4% during the 3rd quarter. Intech Investment Management LLC now owns 27,441 shares of the company’s stock worth $3,646,000 after purchasing an additional 15,104 shares in the last quarter. Finally, Nordea Investment Management AB grew its stake in shares of DaVita by 18.0% during the 4th quarter. Nordea Investment Management AB now owns 338,192 shares of the company’s stock worth $38,321,000 after purchasing an additional 51,607 shares during the period. 90.12% of the stock is owned by hedge funds and other institutional investors.

DaVita Company Profile

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.